Researchers and public health experts point to several overlapping factors, including poverty, lack of insurance coverage, ...

Prostate cancer incidence is increasing, especially in advanced stages, reversing previous declines and slowing mortality rate improvements. Racial disparities persist, with Black and Native American ...

(HealthDay News) — Prostate-specific antigen (PSA) screening likely results in a reduction in prostate cancer-specific mortality, according to a review published online May 15 in the Cochrane Database ...

A new drug combo therapy significantly improved overall survival rates in males with locally advanced prostate cancer. Maskot/Getty ImagesThis article originally appeared on Healthline A new drug ...

What we choose to call cancer may shape patients’ behavior in ways that influence their health outcomes. Relabeling low-grade ...

About 1 in 8 men will be diagnosed with prostate cancer in their lifetime The average age at diagnosis is 67 Less than 1% of the 3.5 million men living with prostate cancer are expected to die from it ...

About The Study: In this study, dropping the cancer label from grade group (GG)1 prostate disease and redefining GG1 prostate disease as a precancerous lesion led to a net reduction in estimated ...

Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive global trial has found that a combination of two medications, enzalutamide ...